Gastrointestinal and nutritional complications of human immunodeficiency virus infection

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 2, 2008, Pages 247-253

  Miller, Tracie L ^a   Agostoni, Carlo ^b   Duggan, Christopher ^c   Guarino, Alfredo ^d   Manary, Mark ^e   Velasco, Carlos A ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF MALAWI   (Malawi)

^f UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASCORBIC ACID; BETA CAROTENE; IMMUNOGLOBULIN; NITAZOXANIDE; NUCLEOTIDE; POLYAMINE; PROBIOTIC AGENT; PROTEINASE INHIBITOR; PUTRESCINE; RETINOL; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROTAVIRUS VACCINE; SPERMIDINE; SPERMINE; TRACE ELEMENT; VITAMIN B GROUP; VITAMIN D; ZINC; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTIFICIAL MILK; BREAST MILK; CRYPTOSPORIDIOSIS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GASTROINTESTINAL DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACRONUTRIENT; MALNUTRITION; MATERNAL NUTRITION; METABOLIC DISORDER; MOTHER CHILD RELATION; NONHUMAN; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS TRANSMISSION; VITAMIN SUPPLEMENTATION; CHILD; CHILD NUTRITION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIET;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI-HIV AGENTS; CHILD; CHILD NUTRITION DISORDERS; CHILD NUTRITION PHYSIOLOGY; DIET; GASTROINTESTINAL DISEASES; HIV INFECTIONS; HUMANS;

EID: 56049102861     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318181b254     Document Type: Review

References (46)

1. Joint United Nations Programme on HIV/AIDS. 2007 Report on the Global AIDS Epidemic. Geneva, Switzerland: WHO/UNAIDS; 2007.
2. Little K, Thorne C, Luo C, et al. Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res 2007;5:139-53.
3. Semba R, Tang A. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr 1999;81:181-9.
4. Dijkhuizen MA. Vitamin A, iron, and zinc deficiency in Indonesia: micronutrient interactions and effects of supplementation [doctoral t.hesis] Wageningen, the Netherlands: Wageningen University; 2001
5. Vogler MA. Update: preventing mother-to-child transmission of HIV. Curr HIV/AIDS Rep 2006;3:59-65.
6. Wanke C. Nutrition and HIV in the international setting. Nutr Clin Care 2005;8:44-8.
7. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994; 94:815-9.
8. Miller TL. Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy. AIDS 2003;17 (Suppl 1):S130- 40.
9. Miller TL, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics 2001;108:1287-96.
10. Chandra RK, Kumari S. Nutrition and immunity: an overview. J Nutr 1994;124 (Suppl 8):1433S-5.
11. Kotler DP, Tierney AR, Wang J, et al. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
12. Carey VJ, Yong FH, Frenkel LM, et al. Pediatric AIDS prognosis using somatic growth velocity. AIDS 1998;12:1361-9.
13. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. Bethesda, MD: Department of Health and Human Services and Centers for Disease Control and Prevention; 2006.
14. Filippini P, Scolastico C, Battaglia M, et al. Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART. J Infect 2006;53:e29-33.
15. Guarino A, Bruzzese E, De Marco G, et al. Management of gastrointestinal disorders in children with HIV infection. Pediatr Drugs 2004;6:347-62.
16. Miller TL, Orav EJ, Martin SR. Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection. Gastroenterology 1991;100: 1296-302.
17. Dandekar S. Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep 2007;4:10-5.
18. Canani RB, Spagnuolo MI, Cirillo P, et al. Ritonavir combination therapy restores intestinal function in children with advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21: 307-12.
19. Knox TA, Spiegelman D, Skinner SC, et al. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000;95:3482-9.
20. Nesheim SR, Kapogiannis BG, Soe MM, et al. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Pediatrics 2007;120:100-9.
21. Miller TL, Awnetwant EL, Evans S, et al. Gastrostomy tube supplementation for HIV-infected children. Pediatrics 1995;96: 696-702.
22. Guarino A, Spagnuolo MI, Giacomet V. Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol Nutr 2002;34: 366-71.
23. Galpin L, Manary MJ, Fleming K, et al. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. Am J Clin Nutr 2005;82:1040-5.
24. Abubakar I, Aliyu SH, Arumugam C, et al. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Co-chrane Database Syst Rev 2007;24:CD004932.
25. Guarino A, Albano F, Canani RB, et al. HIV, fatal rotavirus infection, and treatment options. Lancet 2002;359:74.
26. Guarino A, Albano F, Ashkenazi S, et al. The ESPGHAN/ESPID evidence-based guidelines for the management of acute gastroenteritis in children in Europe expert working group. J Pediatr Gastroenterol Nutr 2008;46:619-21.
27. Ramakrishnan U, Manjrekar R, Rivera J, et al. Micronutrients and pregnancy outcome: a review of the literature. Nutr Res 1999;19: 103-59.
28. Irlam JH, Visser ME, Rollins N, et al. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2005;4:CD003650.
29. Kupka R, Garland M, Msamanga G, et al. Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2005;39:203-10.
30. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351: 1477-82.
31. Eley BS, Sive AA, Abelse L, et al. Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr 2002;22:19-23.
32. Villamor E, Mbise R, Spiegelman D, et al. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 2002;109:E6.
33. Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 2005;366:1862-7.
34. Canani RB, Ruotolo S, Buccigrossi V, et al. Zinc fights diarrhoea in HIV-1 infected children: in-vitro evidence to link clinical data and pathophysiological mechanisms. AIDS 2007;21:108-10.
35. Fawzi WW, Msamanga GI, Kupka R, et al. Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania. Am J Clin Nutr 2007;85: 1335-43.
36. World Health Organization Department of Child and Adolescent Health and Development. Management of the Child With a Serious Infection or Severe Malnutrition. Geneva: WHO; 2000.
37. Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999;281:151-7.
38. Walker VE, Poirier MC. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 2007;48:159-65.
39. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. 2006. http:// www.who.int/hiv/pub/guidelines/art/en Accessed February 5, 2008.
40. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-16.
41. Doherty T, Chopra M, Jackson D, et al. Effectiveness of the WHO/ UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS 2007;21:1791-7.
42. Shapiro RL, Lockman S, Kim S, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 2007;196:562-9.
43. Kuhn L, Sinkala M, Kankasa C, et al. High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLos ONE 2007;2:e1363.
44. WHO, UNICEF, and SCN informal consultation on community-based management of severe malnutrition in children. Food Nutr Bull 2006; 27(Suppl 3):S3-105.
45. Miller TL, Mawn BW, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 2001;107:E77.
46. Brambilla P, Bricalli D, Sala N. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in the absence of lipodystrophy. AIDS 2001;15:2415-22.